Palo Santo is a venture capital firm that focuses on investing in the psychedelic healthcare sector to address the global mental health crisis. Their strategy involves funding a diverse range of psychedelic-focused businesses, including biopharma, drug development, digital therapeutics, healthcare services, and tech-enabled solutions, with a particular emphasis on novel chemical entities and early-stage companies.
Portfolio
1
Fund Size
$55M
Top Stage
Seed
Last 12 Mo
0
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| Ksana Health | Seed | $2M | Jun 2021 |
Top Co-Investors
Panoramic1 shared
Able Partners1 shared
Last updated: 27 February 2026